Aclaris Therapeutics, Inc.
ACRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001557746
No open-market purchases or sales by Aclaris Therapeutics, Inc. insiders were filed in the last 90 days; 148 institutions reported holding it in 13F filings for Q2 2026, worth $630.0M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Aclaris Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 110 | 3 | 115 | +8 |
| Shares | 59.3M | 120.6K | 63.3M | +4.10M (+6.9%) |
| Value | $1.02B | $2.08M | $883.3M | −$136.5M (−13.4%) |
3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Aclaris Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Woodline Partners LP | 621,557 | $8.68M | 0.14% |
| UBS Oconnor LLC | 113,426 | $1.58M | 0.02% |
| Requisite Capital Management, LLC | 45,000 | $628.0K | 0.21% |
| HighPoint Advisor Group LLC | 36,739 | $587.0K | 0.06% |
| State Board of Administration of Florida Retirement System | 18,504 | $258.0K | 0.00% |
| STRS Ohio | 17,900 | $249.0K | 0.00% |
| Mirae Asset Global Investments Co., Ltd. | 16,245 | $227.0K | 0.00% |
| Weiss Multi-Strategy Advisers LLC | 15,000 | $209.0K | 0.01% |
| Campbell & CO Investment Adviser LLC | 13,477 | $188.0K | 0.05% |
| Tudor Investment Corp Et Al | 12,090 | $169.0K | 0.00% |
| Nisa Investment Advisors, LLC | 1,828 | $26.0K | 0.00% |
| Harbour Investments, Inc. | 1,000 | $14.0K | 0.00% |
| Truvestments Capital LLC | 298 | $4.00K | 0.00% |
| Captrust Financial Advisors | 61 | $1.00K | 0.00% |
| CWM, LLC | 16 | $0 | 0.00% |
| Glassman Wealth Services | 16 | $0 | 0.00% |
| Covestor Ltd | 14 | $0 | 0.00% |
Sold out (9)
Institutions that held Aclaris Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Balyasny Asset Management LLC | 209,636 | $3.61M |
| Ghost Tree Capital, LLC | 125,000 | $2.15M |
| Susquehanna International Group, LLP | 29,100 | $502.0K |
| Handelsbanken Fonder AB | 13,800 | $238.0K |
| Simplex Trading, LLC | 12,482 | $215.0K |
| Ikarian Capital, LLC | 12,124 | $208.0K |
| Allspring Global Investments Holdings, LLC | 7,726 | $133.0K |
| Signaturefd, LLC | 43 | $1.00K |
| IFP Advisors, Inc | 5 | – |
Not filed for Q2 2022 yet (3)
Institutions that held Aclaris Therapeutics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Teachers Retirement System of the State of Kentucky | 66,814 | $1.15M |
| Parametric Portfolio Associates LLC | 45,497 | $784.0K |
| Amalgamated Financial Corp. | 8,306 | $143.0K |